Thomson Reuters employs a huge number of pharmaceutical experts, many of them with extensive real-world experience in the industry.
This pool of knowledge includes scientists and researchers, marketing and brand experts, pharmaceutical librarians, strategy and trend analysts and many more. Click on a name range below to learn more about them.
Need a voice? Many of these professionals are available for speaking engagements. Their expertise covers every aspect of pharmaceutical and biotechnology innovation and business intelligence, from clinical trials to generic drugs, from the regulatory landscape to patents, from PR to product strategy. They can bring unique insight, keen analysis, and industry knowledge to any event or presentation. Please contact us to learn more.
BIOINFORMATICS
- Carolyn Finch – Bio Discovery Product Specialist
- Tim Miller – Head of Research
- Josep Prous – Vice President and Chief Scientific Officer
- Colin Williams – Biology and Bioinformatics Product Manager
BUSINESS DEVELOPMENT, LICENSING AND COMPETITIVE INTELLIGENCE
- Victor Camlek – Vice President, Market Intelligence
- Mark Gordon – Director, Product Strategy Business Solutions
- Isabelle Gorrillot – Product Manager, Business Solutions
- John Knapp – Director, Analytics
Clinical
- Miriam Bayes – Head of Scientific & Content Development
- Bonnie Snow – Director, Content Analysis and Development
DRUG DISCOVERY AND R&D
- Miriam Bayes – Head of Scientific & Content Development
- Josep Prous – Vice President and Chief Scientific Officer
- Ann Wescott – Head of Product & Business Development
GENERICS AND API
- Mike Chase-Ortiz – Sr. Director Product Strategy (API Intelligence)
- David Harding – Newport Product Specialist
- Kate Kuhrt – Director, Generics and API Intelligence
Patents
- Mark Markley – Product Specialist
- Don Walter – Training Manager
- Bob Stembridge – Manager, Customer Relations
- Rob Willows – Vice President - Patent Office Relations
Regulatory
- Lawrence Liberti – Vice President, CMR International Institute for Regulatory Science
- Jim Nichols – Vice President, Liquent Software
- Sarah Powell – Executive Director, Regulatory Strategies
- Jane Ricciuti – Director, Regulatory and Pharmaceutical Research
Miriam Bayes – Head of Scientific & Content Development
Miriam Bayes joined Thomson Reuters with the acquisition of Prous Science and is now Head of Scientific & Content Development with a team of more than 80 people selecting, analyzing structuring and indexing the content for our databases and on-line clinical platforms as well as producing 5 different journals in the field of Drug R&D. She also acts as project leader of the Biomarkers database.
Her role includes the management of Prous Science Integrity comprehensive drug discovery and development database with integrated information from different knowledge areas for translational research purposes.
Since joining the company, Miriam has been active in two main areas; participating in the product development of new products and as clinical advisor on CME activities and publications, including numerous programs.
Prior to that, Miriam was chairman of the Phase I Laboratorio Echevarne running the Clinical Trials Unit at the Red Cross Hospital in Barcelona for four years.
Miriam graduated as from the Universidad Navarra, was trained in Clinical Pharmacology and obtained her PhD in Medicine from the University of Barcelona where she lectured on clinical pharmacology in pre- and post-graduate programs.
She is a member of European Society of Clinical Pharmacology and has published and presented at congresses on pharmacokinetics, pharmacodynamics and tolerability of drugs in clinical trials.
Product Expertise:
Victor Camlek – Vice President, Market Intelligence
Victor Camlek is the director of Market Intelligence and Market Research. In this role Victor is responsible for monitoring, assessing, alerting and advising senior management about the issues, impacts and opportunities affecting all our scientific markets.
With over 25 years experience in the industry, Victor has led market intelligence teams and served as a principal market intelligence analyst focused on the telecommunications industry for Telcordia Technologies. He led a team of senior market intelligence analysts who provided information based consulting services for the telecommunications carriers and internal clients. Prior to his 17 years at Telcordia, Victor worked as an information professional in the healthcare and engineering industries.
Currently Network Chair for the SLA CI Division responsible for implementing a mentoring program, Victor is also a candidate for the Chair Elect for the Division and has written a number of articles published in the Bulletin of the SLA Competitive Intelligence Division. In addition he is a member of the NFAIS 2009 conference planning committee.
Victor has a Masters in Library Science from Queens College of the City University of New York and a BA in communications from Hunter College of the City University of NY.
Presentations & Conferences:
Mike Chase-Ortiz – Sr. Director Product Strategy (API Intelligence)
Mike Chace-Ortiz is responsible for managing the long-term development of our products and services for generic companies and innovators. He joined Thomson Reuters (then Newport Strategies) in 2003 and has held a number of roles within the company including leading the Custom Solutions Team, product specialist and new business development Director.
With 15 years in life sciences, Mike has experience of the generic pharmaceuticals industry, APIs, innovator discovery, research, pre-clinical and clinical development, regulatory and commercial processes as well as pharmaceutical information systems. Previously, Mike was a Managing Consultant with PA Consulting Group’s Life Science & Technology practice in Cambridge, MA. He has also held management positions in the Life Science practices of Barnett International/PAREXEL and with Deloitte Consulting in Philadelphia, and Bath, UK.
He obtained a Master of Engineering in Electronics, is a member of the Institute of Electrical Engineers, a Chartered Engineer and in 1985 received the Telecom Equipment Manufacturer’s Association (TEMA) Award for Excellence in R&D.
Product Expertise:
Presentations & Conferences:
Carolyn Finch – Bio Discovery Product Specialist
Carolyn Finch is the Biodiscovery Product Specialist responsible for supporting the sales force as they explore the biological information needs of our customers.
Prior to this Carolyn initiated a product knowledge development program for our global sales force where she managed a team of four trainers and provided product knowledge training to employees across the business. The success of the program was recognised with a Gold Award from the Institute of I.T. Training.
Joining us as an editorial patent analyst, Carolyn was responsible for indexing records for DWPI and GENESEQ databases before joining the training and development department where she designed and delivered technical training for our editorial analysts.
She holds a degree in Biology with European Studies from the University of Sussex which included a year in France, working in a Molecular Biology laboratory.
Product Expertise:
David Harding – Newport Product Specialist
David Harding joined Thomson Reuters in 2005 as a member of Newport’s research team which specializes in gathering competitive intelligence on the worldwide active ingredients market and the generic pharmaceutical sector.
In 2007, Dave took an additional role, travelling worldwide, to support the Thomson Reuters global sales force, with the sales of Newport Vision and Newport Horizon. He received recognition for this work with the Thomson Scientific Outstanding Contribution to Business Award.
Prior to joining the company Dave worked in the legal field conducting patent search and analysis. He obtained a BS in Economics with Business minor from the University of Utah.
Product Expertise:
Presentations & Conferences:
John Knapp – Director, Analytics
John Knapp has more than 15 years of sales and marketing experience, including US and international positions in the medical communications industry. His experience with a wide variety of marketing communication projects, software development, and strategic planning enables him to design, implement, and support the sales and marketing strategies for many aspects of our specialized database products, most notably the Thomson Message Mapping System and its spin-off products and services. His responsibilities include new business development, marketing, and product development.
He is a member of the International Society for Medical Publication Professionals (ISMPP) and the International Publication Planning Association (TIPPA). He holds an MBA in International Marketing degree from the Thunderbird School of Global Management in Glendale, Arizona as well as a Bachelor of Arts degree in Economics from Pomona College in Claremont, California. John speaks Japanese and has lived and worked overseas for eight years.
Kate Kuhrt – Director, Generics and API Intelligence
As the Director of Generic and API Intelligence, Kate Kuhrt oversees Thomson Reuters research efforts regarding the generic and active ingredient industries. Kate joined us with the acquisition of Newport Strategies in 2004. With six years experience, Kate has played an integral role in expanding the worldwide network of industry experts with whom the API intelligence team works to gather and validate the accuracy of data about APIs and their manufacturers. She has published a number of articles discussing the challenges and opportunities for the generics industry in different
parts of the world.
Prior to joining Newport Strategies in 2002, Kate was an Associate at the Pharmaceuticals division of CRA International, a business and litigation consulting firm headquartered in Boston. Kate holds a bachelor’s degree from Bowdoin College in Brunswick, Maine, with a dual major in Economics and Government & Legal Studies.
Product Expertise:
Presentations, Articles & Conferences:
- Opportunities to Sell APIs from Regulated Markets into India and ChinaPDFSCRIP, May 2009
Lawrence Liberti – Vice President, CMR International Institute for Regulatory Science
Larry Liberti has worked in and with the pharmaceutical industry, in the fields of pharmaceutical and clinical research and development for 30 years. He spent nine years at Wyeth Laboratories in Product Development, Clinical R&D, and Medical Affairs. He served as Editorial Director, North America, for ADIS International before starting Pharmaceutical Information Associates (PIA) a company specializing in regulatory writing and regulatory consulting. He was a co-founder of Astrolabe Analytica under which he helped develop and commercialize the Astrolabe Message Mapping System.
Larry is a pharmacist with a master’s degree in pharmacognosy from the Philadelphia College of Pharmacy and Science. He was awarded the status of Regulatory Affairs Certified (RAC) by the Regulatory Affairs Professional Society in 1996, and in 2000 was made a Fellow of the American Medical Writers Association.
He is an active member of the American Medical Writers Association (AMWA), the Regulatory Affairs Professional Society and the Drug Information Association. He was awarded a fellowship of the AMWA and has published several articles on pharmaceutical marketing.
Product Expertise:
Presentations & Conferences:
Mark Markley – Product Specialist
In his current role Mark Markley supports the intellectual property portfolio including Aureka, MicroPatent, and Thomson Innovation. He focuses on increasing the visibility of patent solutions and supporting the current subscriber base.
He has been involved in patent information for over 14 years and is a member of PIUG.
Following graduate school in microbiology and molecular biology Mark worked for patent law firms in Washington DC. He joined Thomson Reuters with the acquisition of Derwent and has held various training and sales roles. He has also worked for STN/Fiz-Karlsruhe as regional sales manager and at LexisNexis as an intellectual property specialist.
Product Expertise:
Presentations & Conferences:
Jim Nichols – Vice President, Liquent Software
As Vice President of Product Strategy and Marketing for regulatory solutions, Jim is responsible for overseeing the delivery of the complete line of products and services which are proven in helping life science companies gain compliance, achieve quality and data integrity to deliver regulatory reports and submissions.
In his time with the company Jim has driven a number of significant milestones namely; defining the market and corporate propositions behind many of its leading publishing and regulatory products and spearheading the company launch into Japan.
Jim is a well-known figure in the document and information publishing field where he is a regular contributor and speaker at conferences both in the US and Europe. He is a member of the Drug Information Association (DIA), Regulatory Affairs Professionals Society (RAPS) and HL7
Prior to joining us Jim directed project management and software operations at Intracorp, the company that pioneered medical management.
Jim was awarded his degree in Mathematics from the Pennsylvania State University.
Product Expertise:
Presentations & Conferences:
Sarah Powell – Executive Director, Regulatory Strategies
Ms. Powell is the Executive Director of Regulatory Strategies for Thomson Reuters. Sarah has 22 years of experience in the pharmaceutical and related regulated industries. For the last 8 years Sarah has worked on a variety of projects related to implementation of regulatory solutions and has contributed to defining product strategies for industry leading software solutions.
While in industry, Sarah performed a variety of roles within the Clinical, Quality, Regulatory Affairs and Regulatory Operations groups. Sarah has extensive experience with preparing regulatory submission for biologic products for submission in the US and EU. She also has detailed knowledge on the requirements for the electronic submissions, including eCTD, and the recently established requirements for electronic submission of labeling information (SPL and PIM).
With over 20 years experience in the industry, Sarah is Chairperson, Regulatory Affairs Special Interest Action Committee, Drug Information Association and a certified member of the Regulatory Affairs Professional Society.
Product Expertise:
Presentations & Conferences:
Josep Prous – Vice President and Chief Scientific Officer
For the last fifteen years, Dr. Prous, Jr. has been responsible for the development of scientific and technological applications, including the design of new information systems, the development of electronic publications and the creation of online continuing education services for the medical community.
A skilled corporate development leader, Josep has established extensive partnerships with leading entities in the scientific information technologies sector and has received various awards including The Outstanding Young People Award by the International Young Chambers in its Business Category.
Before joining Thomson Reuters, he acted as Executive Vice President of Prous Science, a leading knowledge company, in the health and pharmaceutical sciences, established in 1958, and internationally renowned for its accurate and high quality publications and services in drug R&D and clinical medicine.
After receiving a bachelor's degree in Chemistry from the University of Barcelona, Josep completed his doctoral thesis, driving a Medicinal Chemistry project for the discovery of new drugs for Alzheimer's disease. To further expand his capabilities and complement his scientific background, he pursued postgraduate studies that include an MBA from ESADE.
In addition to his commitment to the company, Josep is an active member of Scientific Societies including the American Chemical Society, the American Academy for the Advancement of Science, the Special Libraries Association, the European Federation of Medicinal Chemistry and BioCat.
A regular contributor to the journals of medicinal chemistry published by Prous Science, Josep is instrumental in establishing contacts between editorial committees and opinion leaders in science and medicine. He is Editor in Chief of Drugs of the Future and author of numerous publications in the drug R&D field.
Product Expertise:
Presentations & Conferences:
Jane Ricciuti – Director, Regulatory and Pharmaceutical Research
Jane Ricciuti is Director of Regulatory & Pharmaceutical Research and responsible for researching new products and enhancements in the areas of pharmaceutical and biotechnology regulatory affairs. She also writes expert documents for the IDRAC database on all US regulations pertaining to drugs, biologics, and medical devices.
With over 12 years experience in medical writing and over 7 years in regulatory affairs, Jane has published a number of articles in Regulatory Affairs Focus and Medscape Pharmacists. She is a member of the Regulatory Affairs Professional Society, the Drug Information Association and the American Medical Writers Association.
Jane is a graduate of Albany College of Pharmacy, Albany, New York with a Bachelor of Science degree in Pharmacy and Johns Hopkins University, Baltimore, Maryland with a Master of Administrative Science degree in Management.
She has worked previously as a licensed pharmacist in patient care and clinical trials in acute care, oncology, and surgery settings.
Product Expertise:
Bonnie Snow - Director, Content Analysis and Development
Widely recognized in the information professional community as a subject specialist and expert searcher familiar with pharmaceutical industry information needs and applications, Bonnie Snow has 32 years of experience as an online educator, author, and consultant.
The third edition of her textbook, Drug Information: A Guide to Current Resources, was released in September 2008, jointly published by the Medical Library Association (MLA) and Neal-Schuman. She is also well known as a continuing education instructor responsible for the development and presentation of numerous courses accredited by MLA, the Special Libraries Association, the Drug Information Association, and the American Council on Pharmaceutical Education.
Prior to assuming her current position with Thomson Reuters, Bonnie was Director of Pharmaceutical Market Applications at Dialog for 6 years. She has also served as Director of Healthcare Client Services at Citizen 1 Software (Citeline), Consulting Education Officer for Excerpta Medica, adjunct faculty at Catholic University of America, and Head of References Services at the Philadelphia College of Pharmacy & Science.
She has served as Chair of the Pharmaceutical Division of the Special Libraries Association, the Pharmacy & Drug Information Section of the Medical Library Association, and the Libraries/Educational Resources Section of the American Association of Colleges of Pharmacy. Bonnie is also a member of the Regulatory Affairs Professionals Society and the International Society of Medical Publication Professionals.
Bonnie received an award for Excellence in Online Published Columns (1989) and recognition in the books Secrets of the Super Searchers (1993) and Super Searchers on Health & Medicine (2000). She was also honored with a Distinguished Member Award by the SLA Pharmaceutical Division in 2006.
In addition to three editions of the textbook cited above, Bonnie wrote a series of bimonthly "Cadudeus" columns published in two journals, Online and Database, from 1985 to 1995. Recently, she contributed a chapter on "Drug Regulation" in the book Using the Pharmaceutical Literature (Taylor & Francis, 2006). Her bibliography includes more than 70 publications.
Product Expertise:
Bob Stembridge – Manager, Customer Relations
Bob Stembridge has 25 years experience working within the patent information industry and in his current role is responsible for liaison with customer user groups on behalf of the organization.
He is currently Chair of Patent and Trade Mark Group and has published articles on research and innovation process, patent analysis, patent portfolio management and IPC reform. Bob is also an affiliate member of the Chartered Institute of Library and Information Professionals and a full member of the American Chemical Society. He presents regularly at information conferences and events.
Bob graduated from University of Sussex with a BSc in Chemistry. He joined Thomson Scientific in 1980 and has held various roles in editorial, marketing, sales and product development. Leaving in 1988 for interludes working as Information Analyst specialising in patent analytics at British Petroleum and uropean Sales Liaison with Dialog, he returned to Thomson Reuters in 1996.
Presentations & Conferences:
Don Walter – Training Manager
Donald Walter joined the company over 15 years ago. His primary responsibility is to train users on our scientific and healthcare solutions, specializing in chemical and patent information. He also conducts searches and analyses for legal and industrial clients, with a special emphasis on pharmaceutical and chemical subjects.
He learned his craft at Exxon Research and Engineering, conducting patent and scientific literature searching for clients in the legal and technical departments.
With over 28 years experience in the patent industry and a Ph.D. in Chemistry from Yale, Don is a member of the Patent Information User Group and the American Chemical Society.
Product Expertise:
Presentations & Conferences:
Ann Wescott – Head of Product & Business Development
Ann Wescott joined Thomson Reuters with the acquisition of Prous Science in 2007. She has been with Prous Science for more than 20 years and participated in the development of all the company’s drug R&D databases, starting with diskette and classic online formats in the 1980s and progressing to the Prous Science Integrity drug discovery and development online portal.
Product Expertise:
Colin Williams – Biology and Bioinformatics Product Manager
Colin Williams is the Product Manager for Biology and Bioinformatics where he is responsible for developing solutions for biologists and those working with this information. Colin has been with us since November 2005, his roles have included editorial operations management and commercial leadership in producing and launching new databases which improve the efficiency of biology based research.
He has a degree in Biochemistry and PhD in X-ray Crystallography entitled “The structure of E. coli Aconitase B” both from the University of Sheffield.
After some brief post doctoral work he moved to ASM Scientific, a start-up biotechnology company in Cambridge, UK. Here, as part of a team of three, he developed a novel isothermal DNA amplification technology for use in point of care pathogen detection winning the 2005 Best Biomedical Research Innovation at the Medical Futures Innovation awards.
Colin has published articles in Nature Structural Biology, Molecular Microbiology and PLoS Biology as well as having a number of granted and published patents and patent applications in the field of DNA amplification.
Product Expertise:
Presentations & Conferences:
Rob Willows – Vice President - Patent Office Relations
Rob Willows is Vice President, Patent Offices and Special Accounts. He manages business relationships with Patent and Trademark Offices worldwide, with a special focus on delivering customized patent information solutions that enhance the processes of prior art search and examination within these offices.
Rob has been responsible for successful in-house loads of our data, including the World Patents Index database, at EPO, USPTO, JPO and the Chinese Patent Office. He meets regularly with senior officials of all the major patent offices for strategic discussions on key issues relating to Intellectual Property.
Having a long history with the company, Rob has held a number of senior management and executive positions in Operations, Business Development and New Product Development and also headed up the Intellectual Properties Services strategic business unit.
With over 35 years experience in the field of patent and Scitech information, Rob is a regular speaker at major international IP conferences, including EPIDOS and EAPIC. He is also a member of the Coalition for Patent and Trademark Information Dissemination and PatCom (The Patent Committee).
Product Expertise:
Presentations & Conferences: